Literature DB >> 8275471

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.

M A Caligiuri1, S A Schichman, M P Strout, K Mrózek, M R Baer, S R Frankel, M Barcos, G P Herzig, C M Croce, C D Bloomfield.   

Abstract

Translocations which involve chromosome band 11q23 are frequently found in infants and adults with acute myeloid leukemia (AML) or acute lymphoblastic leukemia. We previously cloned a gene called ALL-1 which spans the 11q23 breakpoint and is rearranged in most cases of leukemia with 11q23 abnormalities. In the present report, we have investigated the occurrence of ALL-1 rearrangement in cases of AML without cytogenetic evidence of 11q23 abnormalities. We detected molecular rearrangements of the ALL-1 gene in 3 of 4 patients with de novo AML and trisomy 11 as a sole chromosomal abnormality. Furthermore, we found DNA rearrangements of ALL-1 in 2 of 19 patients with de novo AML and normal cytogenetics. We conclude that molecular rearrangement of ALL-1 often can be detected in de novo AML, despite the absence of cytogenetic abnormalities involving 11q23.

Entities:  

Mesh:

Year:  1994        PMID: 8275471

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.

Authors:  Venkatasubramanian Dharmarajan; Jeong-Heon Lee; Anamika Patel; David G Skalnik; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2012-06-03       Impact factor: 5.157

Review 2.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 3.  Epigenetic alterations in hematopoietic malignancies.

Authors:  Young Rock Chung; Emma Schatoff; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2012-09-27       Impact factor: 2.490

4.  The PHD fingers of MLL block MLL fusion protein-mediated transformation.

Authors:  Andrew G Muntean; Diane Giannola; Aaron M Udager; Jay L Hess
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

5.  Mechanisms of mixed-lineage leukemia.

Authors:  Andrew G Muntean
Journal:  Int J Hematol Oncol       Date:  2013-06-01

Review 6.  Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.

Authors:  Alison Walker; Guido Marcucci
Journal:  Expert Rev Hematol       Date:  2012-10       Impact factor: 2.929

Review 7.  Epigenetic regulators and their impact on therapy in acute myeloid leukemia.

Authors:  Friederike Pastore; Ross L Levine
Journal:  Haematologica       Date:  2016-03       Impact factor: 9.941

8.  Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.

Authors:  Tadayuki Akagi; Seishi Ogawa; Martin Dugas; Norihiko Kawamata; Go Yamamoto; Yasuhito Nannya; Masashi Sanada; Carl W Miller; Amanda Yung; Susanne Schnittger; Torsten Haferlach; Claudia Haferlach; H Phillip Koeffler
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

9.  DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.

Authors:  Susan P Whitman; Björn Hackanson; Sandya Liyanarachchi; Shujun Liu; Laura J Rush; Kati Maharry; Dean Margeson; Ramana Davuluri; Jing Wen; Tatiana Witte; Li Yu; Chunhui Liu; Clara D Bloomfield; Guido Marcucci; Christoph Plass; Michael A Caligiuri
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

Review 10.  Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.

Authors:  Michael Medinger; Claudia Lengerke; Jakob Passweg
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.